Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression.
Dou, Yun-Ling
Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression. [electronic resource] - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Aug 2014 - 7499-504 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1423-0380
10.1007/s13277-014-1991-0 doi
Carcinoma, Squamous Cell--drug therapy
Cell Proliferation--drug effects
Down-Regulation
E1A-Associated p300 Protein--antagonists & inhibitors
Head and Neck Neoplasms--drug therapy
Humans
Hypopharyngeal Neoplasms--drug therapy
Midazolam--pharmacology
Retinoblastoma Protein--physiology
Squamous Cell Carcinoma of Head and Neck
Tumor Cells, Cultured
Midazolam inhibits the proliferation of human head and neck squamous carcinoma cells by downregulating p300 expression. [electronic resource] - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Aug 2014 - 7499-504 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1423-0380
10.1007/s13277-014-1991-0 doi
Carcinoma, Squamous Cell--drug therapy
Cell Proliferation--drug effects
Down-Regulation
E1A-Associated p300 Protein--antagonists & inhibitors
Head and Neck Neoplasms--drug therapy
Humans
Hypopharyngeal Neoplasms--drug therapy
Midazolam--pharmacology
Retinoblastoma Protein--physiology
Squamous Cell Carcinoma of Head and Neck
Tumor Cells, Cultured